Arizona State Retirement System reduced its stake in Zoetis Inc. (NYSE:ZTS) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 121,700 shares of the company’s stock after selling 100 shares during the period. Arizona State Retirement System’s holdings in Zoetis were worth $7,592,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Gladstone Capital Management LLP bought a new stake in shares of Zoetis during the second quarter valued at about $3,134,000. Ameriprise Financial Inc. increased its stake in shares of Zoetis by 21.1% in the first quarter. Ameriprise Financial Inc. now owns 1,614,416 shares of the company’s stock valued at $86,167,000 after buying an additional 281,139 shares during the last quarter. Harbour Capital Advisors LLC increased its stake in shares of Zoetis by 19.8% in the first quarter. Harbour Capital Advisors LLC now owns 20,005 shares of the company’s stock valued at $1,068,000 after buying an additional 3,300 shares during the last quarter. Hermes Investment Management Ltd. increased its stake in shares of Zoetis by 80.3% in the second quarter. Hermes Investment Management Ltd. now owns 236,350 shares of the company’s stock valued at $14,744,000 after buying an additional 105,276 shares during the last quarter. Finally, AXA increased its stake in shares of Zoetis by 0.8% in the first quarter. AXA now owns 242,831 shares of the company’s stock valued at $12,960,000 after buying an additional 1,900 shares during the last quarter. Institutional investors and hedge funds own 94.51% of the company’s stock.

Zoetis Inc. (NYSE:ZTS) opened at 59.73 on Friday. Zoetis Inc. has a one year low of $46.86 and a one year high of $63.85. The company has a market capitalization of $29.21 billion, a PE ratio of 33.76 and a beta of 1.02. The firm’s 50 day moving average price is $62.20 and its 200-day moving average price is $58.00.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 8th. The company reported $0.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.53. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. Zoetis had a return on equity of 62.49% and a net margin of 17.50%. Zoetis’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. Equities analysts forecast that Zoetis Inc. will post $2.34 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Zoetis Inc. (NYSE:ZTS) Shares Sold by Arizona State Retirement System” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/12/zoetis-inc-nysezts-shares-sold-by-arizona-state-retirement-system.html.

ZTS has been the topic of several research analyst reports. Deutsche Bank AG restated a “buy” rating and issued a $65.00 price objective (up previously from $62.00) on shares of Zoetis in a research note on Monday, July 17th. BMO Capital Markets restated a “buy” rating and issued a $60.00 price objective on shares of Zoetis in a research note on Thursday, May 4th. Zacks Investment Research upgraded shares of Zoetis from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research note on Wednesday, May 10th. Argus restated a “buy” rating and issued a $69.00 price objective (up previously from $60.00) on shares of Zoetis in a research note on Tuesday, May 30th. Finally, Hilliard Lyons initiated coverage on shares of Zoetis in a research note on Tuesday, June 20th. They issued a “buy” rating and a $77.00 price objective on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the stock. Zoetis has an average rating of “Buy” and an average price target of $64.78.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.